-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Underweight on Helmerich & Payne, Raises Price Target to $39

Benzinga·05/14/2026 11:32:06
Listen to the news
Morgan Stanley analyst Daniel Kutz maintains Helmerich & Payne (NYSE:HP) with a Underweight and raises the price target from $35 to $39.